The sector’s latest impact report shows that demand for capital is continuing to outstrip supply. NBR talks to Kwetta, Nilo and Shower Canary on their fundraising efforts.
The Kiwi company begins a trial with NZ Post next month.
The respiratory healthcare company is firing on all cylinders.
Simon Rolland has an eight-figure war chest after selling out of financial services firms this year.
The New Zealand buy-now, pay-later company ceased operations in June.
Fintech startup now has bilateral deals with all four major banks for its merchant payment service, but CEO says more work required.
Founder Jonathan Ring says he’s confident of raising more following new approaches.
The seed round is still open for oversubscriptions.
The NZ Healthtech Investment Report shows slight growth in overall investment but a sharp drop-off for later stage capital.
Appetise, formerly MenuAid, has a new business strategy and new investment from Icehouse Ventures and Sydneysiders OIF Ventures.